AACCE Investments
ScreenerStocksIndicesPicksETFsBlogPricing

© 2026 ACCE Investments. All rights reserved.

ACCE Investments - Institutional-grade stock research for retail investors | BetaList
IndicesStocksETFsScreenerBlogGlossaryCompareMarket dataAdvisors
TermsPrivacyCookiesDisclaimerLegal noticeProfessional termsAboutContact
IPS.PA

Ipsos SA (IPS.PA) fair value

Industrials · Consulting Services · Euronext Paris · France
€35.30-5.56%
Market cap €1.5BNext earnings 2027-02-10Updated Oct 23, 2026
Add earnings to calendarGoogle
Our verdict
Trades 42% below our fair value
Price
€35.30
Model fair valueConfidence: good
€60.49
Model range
€24.83 to €105
Fair value €60.49
Price €35.30
4 models fit Ipsos SA and they partly agree: 2 of 4 land within 15% of the average.
Two or more of our models back this value.
Large discount(i)Gold80
Valued as a mature, profitable company: Discounted cash flow, P/E comparison, EV/EBITDA comparison, Graham number, and Dividend discount.
ACCE opinionIpsos SA (IPS.PA)
Fair value (4 models)
€60.49
ACCE price target
€48.00
Rating
Undervalued
Horizon
12 months
Fair value published on 23 Oct 2026, 11:04 CEST.
ACCE price target published on 23 Oct 2026, 01:53 CEST.
Rating published on 23 Oct 2026, 11:04 CEST.
Price used: €35.30 at the close on 23 Oct 2026, 17:30 CEST.
Models: Discounted cash flow, EV/EBITDA comparison, Graham number, and Dividend discount.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Full methodology
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
Price vs fair value
41.6% below
+71.4% to fair value
ACCE score
62
out of 100
P/E
8.8x
forward 6.2x
1-year return
+3.9%
Dividend yield
5.41%

Ipsos SA in four questions

Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
OverviewAsk ACCEValuationQualityAnalystsSmart MoneyCompareNews and Record

Overview

ACCE thesis

Ipsos sells market research and consumer insight, from survey panels and brand tracking studies to its data-science and advisory services, mostly to consumer goods and media clients. Its moat rests on proprietary panels and long-running tracking datasets that are costly to replicate and sticky once embedded in a client's planning cycle. Revenue growth has stalled at 1.3%, so the case rests on margin and cash generation rather than top-line momentum, and an 8.5% operating margin against a 67.5% gross margin shows where the upside would come from if costs are reined in. At 9.3 times trailing and 6.6 times forward earnings, with an 11.9% ROE, the market is pricing in little recovery. The question for a deeper look is whether the operating margin can expand while growth holds positive, since that would close much of the gap to the multiple.

AI-assisted·How I use AIWritten Oct 23, 2026

Next results

Feb 10, 2027
We update the fair value about 2 days after the results, once the new figures are filed.Add to calendarGoogle

Walk me through this stock

Plain-English pros, cons, and what to watch. Pro feature.

PRO

Ask ACCE

Valuation

INVESTOR
Where IPS.PA's valuation models land
Price
€35.30
Model fair value
€60.49
Model range
€24.83 to €105
Fair value €60.49
Price €35.30
The price sits inside the model range.
Model
Fair value
Upside
Discounted cash flow
Dividend discount
EV/EBITDA comparison
Graham number
P/E comparison
Create a free account: 5 full stock pages a month, no card.

See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.

Quality

INVESTOR
Quality and conviction INVESTOR FEATURE

The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.

  • +A plain reason under every score
  • +Conviction breakdown and growth / value / quality / momentum scores
  • +Score history: how each score moved over time

Analysts

Wall Street consensus

No analyst coverage yet.
Analyst intelligence INVESTOR FEATURE

The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.

  • +Price-target low / average / high vs the current price, with implied upside
  • +Forward revenue and EPS consensus by fiscal year
  • +ACCE fair-value models lined up against the Street

Smart Money

PRO

In one line

Trades are only made public after a delay. We show the delay so you know how old the news is.

Company insiders
No trades filed
Last 90 days
Congress
No trades filed
Last 180 days
Average delay
No trades filed
From trade to public filing
Do politicians beat the market? Our backtest →
Smart money tracking PRO FEATURE

Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.

  • +Quarter-over-quarter institutional position changes
  • +Every insider and Congress trade, with how late it was disclosed
  • +Active 13D activist filings and top holders

Compare

Where it sits vs peers

News and Record

Recent performance

1 week
-3.6%
1 month
+0.6%
3 months
-12.0%
6 months
+2.0%
YTD
+3.0%
1 year
+3.9%

Recommendation history, last 12 months

DateTypeNewPreviousPrice
23 Oct 2026, 11:04 CESTFair value€60.49first publication€37.38
23 Oct 2026, 11:04 CESTRatingUndervaluedfirst publication€37.38
23 Oct 2026, 01:53 CESTACCE price target€48.00first publication€37.38

This analysis is not personalised investment advice and does not take your situation, objectives or risk tolerance into account. ACCE Investments is not an authorised investment firm.

Investing in shares carries a risk of losing capital. The value of an investment can go down as well as up.

This security trades in EUR. Exchange-rate movements can increase or reduce the result in your own currency.

Valuation horizon: 12 months from the publication date.

Conflicts of interest. ACCE Investments is operated by Adrien Chantreuil, who may hold personal positions in the securities analysed. Positions are declared on each security. ACCE receives no payment from the companies analysed or from any intermediary for this analysis.

Get the full IPS.PA page, free

Every model, the scenarios, fair value history, AI notes and the four questions. 5 full stock pages every month on the free plan, no card.

Free accounts get 5 full stock pages a month, including the full page.

Snapshot

Growth19Value100Quality67Momentum63Total62
Valuation
Trailing P/E
8.8x
Forward P/E
6.2x
PEG
no data
P/B
0.95x
EV / Revenue
0.8x
Book value/sh
€36.49
Enterprise value
€2.1B
Profitability
ROE
11.9%
FCF yield
14.82%
ROIC
6.9%
Health and risk
Debt / equity
0.42
Dividend yield
5.41%
Beta
0.65

Price

+3.7% · 1Y

Ask anything about IPS.PA

Answered from Ipsos SA fundamentals + recent valuations. Every number shows its source and date.

This stock Peer Peer median weaker → stronger
P/Ebetter than 100% of peers
low 8.8x8.8xhigh 47.2x
ROEbetter than 33% of peers
low 6%12%high 27%
Div yieldbetter than 100% of peers
low 0.0%5.4%high 5.4%

Peers

Prices Oct 23, 2026
CompanyPriceFair valuevs fair valueP/EROEQualityScore
IPS.PA Ipsos SA€35.30€6042% below8.8x11.9%6762
ICFI ICF International Inc. Common Stock$94.40$10611% below18.8x8.6%5663
CRAI CRA International Inc. Common Stock$200.14$14043% above26.8x26.0%7470
HURN Huron Consulting Group Inc. Common Stock$195.69$14634% above28.0x26.9%6977
FCN FTI Consulting Inc. Common Stock$157.24$1665% below18.9x15.6%6450
SBC SBC Medical Group Holdings Incorporated Common Stock$5.28$618% below11.2x18.9%9589
BTS-B.ST BTS Group AB (publ)kr 231.00--47.2x6.3%6061

Sector report card

Where IPS.PA ranks against its sector peers on each metric.

Computing percentiles…